Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CAS 5987 82 6. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113185419B reveals a greener 4-step route for oxybuprocaine hydrochloride, eliminating genotoxic risks and enabling cost-effective commercial scale-up.